FENC Fennec Pharmaceuticals Inc.
Price Chart
Executive Summary
Fennec Pharmaceuticals announced it will release Q1 2026 financial results on May 14, 2026. The press release contains no financial data for the current period; the synthetic earnings context shows a Q4 2025 EPS miss of -499.9% vs consensus, but this is not part of the actual filing. The stock has historically declined following FENC reports, with an average T+20 loss of -13.08% across prior calls.
Actionable Insight
This is a routine earnings date announcement with no financial content. Monitor the May 14 release for actual Q1 2026 results and any guidance updates. Given the stock's historical negative drift following FENC reports, traders should watch for potential downside if results disappoint.
Key Facts
- Q1 2026 earnings release scheduled for May 14, 2026 before market open
- Conference call and webcast at 8:30 a.m. ET on May 14, 2026
- No financial results or guidance included in this press release
- Historical performance shows average T+20 loss of -13.08% on prior FENC reports
Financial Impact
No financial data in this filing
Risk Factors
- No current financial data to assess — risk of adverse results on May 14
- Historical pattern of negative stock movement following FENC filings
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3289755 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 22, 2026
21d ago
|
8-K
| $9.89 $9.88 | ▼ −0.10% | ▼ −1.18% | $9.00 (−9.00%) |
|
May 18, 2026
25d ago
|
8-K
| $9.76 $9.97 | ▲ +2.15% | ▼ −0.15% | $9.00 (−7.79%) |
|
May 14, 2026
4w ago
|
Press Release
| $9.24 $9.97 | ▲ +7.90% | ▲ +8.62% | $9.00 (−2.60%) |
|
May 7, 2026
5w ago
|
Press Release
| $6.90 $6.77 | ▼ −1.88% | ▼ −3.39% | $9.00 (+30.43%) |
|
Apr 28, 2026
6w ago
|
8-K
| $6.26 $7.18 | ▲ +14.70% | ▲ +11.59% | $9.00 (+43.77%) |
|
Apr 22, 2026
7w ago
|
8-K
| $6.66 $6.26 | ▼ −6.01% | ▼ −7.48% | $9.00 (+35.14%) |
|
Apr 7, 2026
9w ago
|
8-K
| $6.49 $6.50 | ▲ +0.15% | ▼ −3.36% | $9.00 (+38.67%) |
|
Apr 7, 2026
9w ago
|
Press Release
| $6.32 $6.25 | ▼ −1.11% | ▼ −6.44% | $9.00 (+42.41%) |
|
Mar 24, 2026
11w ago
|
Press Release
| $6.02 $6.15 | ▲ +2.16% | ▲ +2.58% | $9.00 (+49.50%) |
|
Mar 18, 2026
12w ago
|
Press Release
| $7.47 $6.17 | ▼ −17.40% | ▼ −16.69% | $9.00 (+20.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access